יתרות מזומנים בחישוב למניה Atossa Pharma (ATOS)

Atossa Therapeutics (ATOS) monetizes proprietary breast cancer treatments leveraging patent protection. This chart of cash per share illustrates the market response, where the latest parameter is 2.08. Production risks are minimized through the use of external CDMO facilities. Capital stability ensures independence from macroeconomic trends, transforming the company into a reliable defensive asset for investors.
פילוחי מדדים מקיפים ואנליטיקה עבור Atossa Therapeutics, Inc. (ATOS)

This indicator determines the actual financial cushion by calculating the share of confirmed cash per common share to assess liquidity. Analyzing the free liquidity per share reveals whether the existing capital of Atossa Therapeutics (ATOS) is sufficient to fund costly, multi-year clinical trials involving scientists, despite the automation of drug production.